Evidence map›Paper›PMID 32774332›Full record

ArticleFrontiers in immunology2020

T-bet Expression in Peripheral Th17.0 Cells Is Associated With Pulmonary Function Changes in Sarcoidosis.

Nicholas K Arger, Siddharth Machiraju, Isabel E Allen, Prescott G Woodruff, Laura L Koth

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. HLA-DRRespiratory research · 2026
    Article
  2. Review
  3. Pulmonary toxicity of immune checkpoint immunotherapy.The Journal of clinical investigation · 2024
    Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Inflammatory Pathways in Sarcoidosis.Advances in experimental medicine and biology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Nicholas K ArgerDivision of Pulmonary and Critical Care, University of California, San Francisco, San Francisco, CA, United States.
Siddharth MachirajuDivision of Pulmonary and Critical Care, University of California, San Francisco, San Francisco, CA, United States.
Isabel E AllenDepartment of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, United States.
Prescott G WoodruffDivision of Pulmonary and Critical Care, University of California, San Francisco, San Francisco, CA, United States.
Laura L KothDivision of Pulmonary and Critical Care, University of California, San Francisco, San Francisco, CA, United States.
University of California, San Francisco · US

Funding

MUTIDISCIPLINARY TRAINING PROGRAM IN LUNG DISEASEST32HL007185 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI David J Erle, LAURENCE HUANG · 1985 to 2026
$24.6M
Mentoring Research in Precision Medicine for Lung DiseaseK24HL137013 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PRESCOTT G WOODRUFF · 2017 to 2026
$1.2M
NHLBI NIH HHS K24 HL137013NHLBI NIH HHS T32 HL007185
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedBiomarkersBronchoalveolar Lavage FluidCase-Control StudiesFemaleHumansInterferon-gammaLungMaleMiddle AgedNuclear Receptor Subfamily 1, Group F, Member 3PrognosisSarcoidosis, PulmonaryT-bet Transcription FactorT-Box Domain ProteinsBiomarkersInterferon-gammaNuclear Receptor Subfamily 1, Group F, Member 3RORC protein, humanT-bet Transcription FactorT-Box Domain Proteinschemokineinterferon-gammaRORγtsarcoidosisT-betTh1Th17Th17.1

Identifiers

PMID32774332
PMCPMC7387715
OpenAlexW3037313123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.